Mogrify is a biotech company advancing cell therapies. The company develops a proprietary direct cellular conversion technology, which makes it possible to transform a mature human cell type into another without going through a pluripotent stem cell- or progenitor cell-state.
|Employees (est.) (Dec 2020)||51|
Mogrify total Funding
Mogrify latest funding size
Time since last funding
|a year ago|
|24 Haymarket, Darrin Disley, Parkwalk Advisors, Ahren Innovation Capital, University of Bristol Enterprise Fund|
Mogrify has 582 Twitter Followers. The number of followers has increased 2.7% month over month and increased 15.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Mogrify founded?
Mogrify was founded in 2016.
How many employees does Mogrify have?
Mogrify has 51 employees.
Who are Mogrify competitors?
Competitors of Mogrify include Pluristem Therapeutics, Immunicom and AbCellera Biologics.
Where is Mogrify headquarters?
Mogrify headquarters is located at 25 Cambridge Science Park Milton Rd, Cambridge.
Where are Mogrify offices?
Mogrify has an office in Cambridge.
How many offices does Mogrify have?
Mogrify has 1 office.
Receive alerts for 300+ data fields across thousands of companies